CIK 0001824293 · <br>Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824369909
- Phone
- (619) 400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-23 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +129,730 | $0.69 | $89K | 129,730 |
| 2025-01-23 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +30,297 | $0.69 | $21K | 30,297 |
| 2025-01-23 | Baker David Charles Director | Grant or award · Stock Option (Right to Buy) | +30,297 | $0.69 | $21K | 30,297 |
| 2025-01-23 | Szekeres David Leslie Director | Grant or award · Stock Option (Right to Buy) | +51,937 | $0.69 | $36K | 51,937 |
| 2025-01-23 | Rongen Roelof Director | Grant or award · Stock Option (Right to Buy) | +30,297 | $0.69 | $21K | 30,297 |
| 2023-09-22 | Kelly Leanne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +83,333 | $1.52 | $127K | 83,333 |
| 2023-08-10 | Szekeres David Leslie Director | Grant or award · Stock Option (Right to Buy) | +34,483 | $2.90 | $100K | 34,483 |
| 2023-08-10 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +34,483 | $2.90 | $100K | 34,483 |
| 2023-08-10 | Rongen Roelof Director | Grant or award · Stock Option (Right to Buy) | +34,483 | $2.90 | $100K | 34,483 |
| 2023-08-10 | Baker David Charles Director | Grant or award · Stock Option (Right to Buy) | +34,483 | $2.90 | $100K | 34,483 |
| 2023-04-21 | Hertz Walter Marc Chief Executive Officer | Grant or award | +385,510 | 385,510 | ||
| 2023-04-21 | Agro Albert Chief Medical Officer | Grant or award | +172,189 | 172,189 | ||
| 2023-04-21 | Chaturvedi Vipin Chief Scientific Officer | Grant or award | +172,189 | 172,189 | ||
| 2022-12-13 | Thorell Marella Director | Other disposition | −28,517 | 9,506 | ||
| 2022-07-01 | Thorell Marella Director | Grant or award | +38,023 | 38,023 | ||
| 2022-06-09 | Ammer Richard Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-09 | Payne Joseph E Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-09 | Thorell Marella Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-02-23 | Chhabra Meenu Director | Grant or award · Stock Option (Right to Buy) | +15,000 | $7.67 | $115K | 15,000 |
| 2022-02-15 | Baker David Charles Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +61,000 | $5.63 | $343K | 61,000 |
Page 2 of 3 · 60 trades